The Tale Of Two Clinical Supply Chains: The Risks Of Fragmented Systems

In clinical trials, robust supply chain management is essential for safeguarding patient safety and maintaining regulatory compliance. This study examines two contrasting approaches: a fragmented, manual system and a centralized inventory management system. The fragmented approach poses significant challenges, as exemplified by Crystal, a Clinical Supplies Manager at BestPharm, who faces difficulties in tracking and recalling contaminated drug batches due to disjointed data spread across spreadsheets, emails, and paper records. This not only jeopardizes patient safety but also complicates adherence to regulatory standards. In contrast, a centralized system, such as Signant Health's GxP Inventory, offers a streamlined solution by providing immediate access to comprehensive supply chain data. This centralized approach enables efficient management of recalls and minimizes contamination risks, underscoring the critical role of centralization in enhancing safety, operational efficiency, and protecting investments in clinical trials. The findings highlight the imperative for pharmaceutical companies to adopt centralized systems to ensure the integrity and success of clinical trials.
Get unlimited access to:
Enter your credentials below to log in. Not yet a member of Clinical Supply Leader? Subscribe today.